Scientists use tiny ketamine doses to map brain for schizophrenia clues
NCT ID NCT04589208
Summary
This study aims to find the lowest dose of ketamine that produces a measurable brain signal in healthy volunteers. Researchers will use brain scans to see how the drug affects brain activity, hoping this method can later help test new schizophrenia medications. The study involves 35 healthy adults who will receive two small, weight-based ketamine doses during MRI scans at least a week apart.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
New York State Psychiatric
New York, New York, 10023, United States
Conditions
Explore the condition pages connected to this study.